Edition:
United States

Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

13.38USD
16 Nov 2018
Change (% chg)

$1.88 (+16.35%)
Prev Close
$11.50
Open
$12.10
Day's High
$13.93
Day's Low
$11.74
Volume
199,020
Avg. Vol
57,283
52-wk High
$30.70
52-wk Low
$10.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.73 December 17 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 3
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.83 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.00 0.01 0.00 0.00
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 5 10.50 10.51 10.49 7.36
Year Ending Dec-19 6 8.69 28.07 0.00 33.89
Earnings (per share)
Quarter Ending Dec-18 6 -0.73 -0.68 -0.76 -0.67
Quarter Ending Mar-19 1 -0.76 -0.76 -0.76 -0.83
Year Ending Dec-18 6 -2.23 -2.15 -2.28 -2.46
Year Ending Dec-19 6 -2.73 -1.99 -3.25 -1.92

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.01 0.01 0.01 89.66
Quarter Ending Jun-18 0.01 0.00 0.01 81.82
Quarter Ending Mar-18 0.01 10.48 10.47 118,979.55
Quarter Ending Dec-17 3.30 0.01 3.29 99.64
Quarter Ending Sep-17 0.01 143.84 143.83 1,229,335.88

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.00 0.00 0.01 0.01 0.00
Quarter Ending Mar-19 0.00 0.00 0.00 0.00 --
Year Ending Dec-18 10.50 10.50 10.50 10.50 7.36
Year Ending Dec-19 8.69 8.69 8.69 8.69 33.89

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 2 1
Year Ending Dec-19 0 0 0 0
Earnings